(Q73525619)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10708676%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

title

The effect of serotonin(1A) receptor agonism on antipsychotic drug-induced dopamine release in rat striatum and nucleus accumbens (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10708676%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

author name string

J Ichikawa

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10708676%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

H Y Meltzer

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10708676%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

publication date

1 March 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10708676%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10708676%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

858

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10708676%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10708676%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

252-263

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10708676%20AND%20SRC:MED&resulttype=core&format=json

Evidence for selective inhibition of limbic forebrain dopamine synthesis by 8-OH-DPAT in the rat

4 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902346-X

The 5-HT1A receptor selective ligands, (R)-8-OH-DPAT and (S)-UH-301, differentially affect the activity of midbrain dopamine neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902346-X

5-HT1A receptor agonist properties of the antipsychotic, nemonapride: comparison with bromerguride and clozapine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902346-X

Behavioural evidence for a functional interaction between central 5-HT2 and 5-HT1A receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902346-X

Facilitation of dopamine release in vivo by serotonin agonists: studies with microdialysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902346-X

Resolved N,N-dialkylated 2-amino-8-hydroxytetralins: stereoselective interactions with 5-HT1A receptors in the brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902346-X

Serotonergic and dopaminergic aspects of neuroleptic-induced extrapyramidal syndromes in nonhuman primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902346-X

Reversal of haloperidol-induced extrapyramidal side effects in cebus monkeys by 8-hydroxy-2-(di-n-propylamino)tetralin and its enantiomers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902346-X

Acetylcholinesterase inhibitors block acetylcholine-evoked release of dopamine in rat striatum, in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902346-X

Dopamine in schizophrenia: a review and reconceptualization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902346-X

5-HT1A receptor agonists: recent developments and controversial issues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902346-X

Regional specific effects of clozapine and haloperidol on GABA and dopamine release in rat basal ganglia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902346-X

A pharmacological profile of the selective silent 5-HT1A receptor antagonist, WAY-100635

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902346-X

Alterations in the cortical serotonergic system in schizophrenia: a postmortem study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902346-X

Amperozide--a new putatively antipsychotic drug with a limbic mode of action on dopamine mediated behaviour.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902346-X

Increase in serotonin 5-HT1A receptors in prefrontal and temporal cortices of brains from patients with chronic schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902346-X

Catalepsy as a rodent model for detecting antipsychotic drugs with extrapyramidal side effect liability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902346-X

8-OH-DPAT-induced release of hippocampal noradrenaline in vivo: evidence for a role of both 5-HT1A and dopamine D1 receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902346-X

Amperozide, a novel antipsychotic drug, inhibits the ability of d-amphetamine to increase dopamine release in vivo in rat striatum and nucleus accumbens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902346-X

R(+)-8-OH-DPAT, a 5-HT1A receptor agonist, inhibits amphetamine-induced dopamine release in rat striatum and nucleus accumbens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902346-X

Effect of antipsychotic drugs on extracellular serotonin levels in rat medial prefrontal cortex and nucleus accumbens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902346-X

Two selective 5-HT1A receptor antagonists, WAY-100 635 and NDL-249, stimulate locomotion in rats acclimatised to their environment and alter their behaviour: a behavioural analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902346-X

The anxiolytic serotonin 5-HT1A receptor agonists buspirone, ipsapirone and gepirone are inhibitors of tyrosine hydroxylation in rat striatum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902346-X

R(+)-8-OH-DPAT, a 5-HT1A receptor agonist, inhibits amphetamine-induced serotonin and dopamine release in rat medial prefrontal cortex.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902346-X

Induction of burst firing in ventral tegmental area dopaminergic neurons by activation of serotonin (5-HT)1A receptors: WAY 100,635-reversible actions of the highly selective ligands, flesinoxan and S 15535.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902346-X

Interaction of antipsychotic drugs with neurotransmitter receptor sites in vitro and in vivo in relation to pharmacological and clinical effects: role of 5HT2 receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902346-X

Efficacy and safety of risperidone in the long-term treatment of patients with schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902346-X

8-OH-DPAT, a 5-HT1A agonist and ritanserin, a 5-HT2A/C antagonist, reverse haloperidol-induced catalepsy in rats independently of striatal dopamine release

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902346-X

Risperidone in the treatment of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902346-X

5-HT3 receptor mediated dopamine release in the nucleus accumbens during withdrawal from continuous cocaine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902346-X

The dopamine hypothesis of schizophrenia: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902346-X

Serotonin (5-HT)2C receptors tonically inhibit dopamine (DA) and noradrenaline (NA), but not 5-HT, release in the frontal cortex in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902346-X

The putative 5-HT1A receptor antagonist DU125530 blocks the discriminative stimulus of the 5-HT1A receptor agonist flesinoxan in pigeons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902346-X

Agonist and antagonist actions of antipsychotic agents at 5-HT1A receptors: a [35S]GTPgammaS binding study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902346-X

The 5-HT1A receptor antagonist (S)-UH-301 decreases dopamine release in the rat nucleus accumbens and striatum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902346-X

Studies of four novel diphenylbutylpiperazinepyridyl derivatives on release and inhibition of reuptake of dopamine, serotonin and noradrenaline by rat brain in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902346-X

In vivo modulation of acetylcholine in the nucleus accumbens of freely moving rats: I. Inhibition by serotonin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902346-X

5-HT1a agonist +/-8-OH-DPAT modulates basal and stress-induced changes in medial prefrontal cortical dopamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902346-X

Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902346-X

Amphetamine psychosis: a "model" schizophrenia mediated by catecholamines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902346-X

Serotonin1A receptors are increased in postmortem prefrontal cortex in schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902346-X

Increase of noradrenaline release in the hypothalamus of freely moving rat by postsynaptic 5‐hydroxytryptamine1A receptor activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902346-X

Increase of extracellular dopamine in the prefrontal cortex: a trait of drugs with antidepressant potential?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902346-X

Antipsychotic-like profile of combined treatment with raclopride and 8-OH-DPAT in the rat: enhancement of antipsychotic-like effects without catalepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902346-X

Serotonergic mechanisms in neuroleptic-induced catalepsy in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902346-X

Flesinoxan lowers blood pressure and heart rate in cats via 5-HT1A receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902346-X

Differential Effects of Dopamine Antagonists on Evoked Dopamine Release from Slices of Striatum and Nucleus Accumbens in Rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902346-X

10.1016/S0006-8993(99)02346-X

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10708676%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference